Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases GlobeNewswire - Tue Jul 8, 6:30AM CDT

PSTV : 0.3332 (+10.88%)
Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases GlobeNewswire - Mon Jun 30, 6:30AM CDT

PSTV : 0.3332 (+10.88%)
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary GlobeNewswire - Thu Jun 26, 6:30AM CDT

PSTV : 0.3332 (+10.88%)
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET GlobeNewswire - Wed Jun 25, 3:15PM CDT

PSTV : 0.3332 (+10.88%)
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer GlobeNewswire - Wed Jun 25, 6:30AM CDT

PSTV : 0.3332 (+10.88%)
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing GlobeNewswire - Tue Jun 24, 6:30AM CDT

PSTV : 0.3332 (+10.88%)
Plus: Q1 Earnings Snapshot AP - Fri May 30, 3:23PM CDT

Plus: Q1 Earnings Snapshot

PSTV : 0.3332 (+10.88%)
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights GlobeNewswire - Fri May 30, 3:15PM CDT

PSTV : 0.3332 (+10.88%)
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q GlobeNewswire - Fri May 23, 3:15PM CDT

PSTV : 0.3332 (+10.88%)
Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM) GlobeNewswire - Wed May 14, 6:30AM CDT

PSTV : 0.3332 (+10.88%)

Barchart Exclusives

Up Nearly 20% in a Month, Is This Turnaround Dividend Stock Still a Buy in July? Barchart - Tue Jul 8, 6:30PM CDT
Nike has a dividend yield of around 2.1% and while the stock has gained 20% over the last month, it’s still not too late to buy shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot